Shopping Cart 0
Cart Subtotal
USD 0

Agios Pharmaceuticals Inc (AGIO) - Financial and Strategic SWOT Analysis Review

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 300

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 600

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 900
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

Agios Pharmaceuticals Inc (Agios) is a biopharmaceutical company that focuses on the discovery and development of investigational medicines for the treatment of cancer and rare genetic metabolic disorders. The company's products include IDHIFA, an oral targeted inhibitor of the mutated IDH2 enzyme used for the treatment of patients with R/R acute myeloid leukemia (AML); and TIBSOVO (ivosidenib), a prescription medicine used to treat adults with AML. Its pipeline products include AG-881, a pan-IDH mutant inhibitor intended for the treatment of hematologic malignancies and solid tumors; AG-270, an inhibitor of methionine adenosyltransferase 2a; and Mitapivat, a potent activator intended for the treatment of patients with pyruvate kinase deficiency. Agios is headquartered in Cambridge, Massachusetts, the US.

Agios Pharmaceuticals Inc Key Recent Developments

Feb 25,2019: Agios Reports Updated Data from Phase 1 Study of Ivosidenib in Combination with Azacitidine Demonstrating Deep and Durable Responses in Newly Diagnosed IDH1 Mutant Acute Myeloid Leukemia (AML) Patients

Feb 14,2019: Agios reports fourth quarter and full year 2018 financial results

Nov 01,2018: Agios reports third quarter 2018 financial results

Sep 05,2018: 2018 Veeva R&D summit to showcase advances for speeding product development

Sep 04,2018: Agios Announces Chief Executive Officer Succession Plan

This comprehensive SWOT profile of Agios Pharmaceuticals Inc provides you an in-depth strategic analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData's 'Profile on Demand' service, covering over 50,000 of the world's leading companies. Once purchased, GlobalData's highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Agios Pharmaceuticals Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

READ MORE

Table Of Content

Scope

Table of Contents

Section 1-About the Company

Agios Pharmaceuticals Inc-Key Information

Agios Pharmaceuticals Inc-Overview

Agios Pharmaceuticals Inc-Key Employees

Agios Pharmaceuticals Inc-Key Employee Biographies

Agios Pharmaceuticals Inc-Key Operational Heads

Agios Pharmaceuticals Inc-Major Products and Services

Agios Pharmaceuticals Inc-History

Agios Pharmaceuticals Inc-Company Statement

Agios Pharmaceuticals Inc-Locations And Subsidiaries

Agios Pharmaceuticals Inc-Key Manufacturing facilities

Head Office

Other Locations & Subsidiaries

Section 2-Company Analysis

Agios Pharmaceuticals Inc-Business Description

Agios Pharmaceuticals Inc-Corporate Strategy

Agios Pharmaceuticals Inc-SWOT Analysis

SWOT Analysis-Overview

Agios Pharmaceuticals Inc-Strengths

Agios Pharmaceuticals Inc-Weaknesses

Agios Pharmaceuticals Inc-Opportunities

Agios Pharmaceuticals Inc-Threats

Agios Pharmaceuticals Inc-Key Competitors

Section 3-Company Financial Performance Charts

Agios Pharmaceuticals Inc-Financial Ratios

Financial Ratios-Capital Market Ratios

Financial Ratios-Annual Ratios

Financial Ratios-Interim Ratios

Financial Ratios-Ratio Charts

Section 4-Appendix

Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer

Note*: Some sections may be missing if data is unavailable for the company


List Of Figure

List of Figures

Agios Pharmaceuticals Inc, Performance Chart

Agios Pharmaceuticals Inc, Ratio Charts


List Of Table

List of Tables

Agios Pharmaceuticals Inc, Key Information

Agios Pharmaceuticals Inc, Key Ratios

Agios Pharmaceuticals Inc, Share Data

Agios Pharmaceuticals Inc, Major Products and Services

Agios Pharmaceuticals Inc, History

Agios Pharmaceuticals Inc, Key Employees

Agios Pharmaceuticals Inc, Key Employee Biographies

Agios Pharmaceuticals Inc, Key Operational Heads

Agios Pharmaceuticals Inc, Other Locations

Agios Pharmaceuticals Inc, Subsidiaries

Agios Pharmaceuticals Inc, Key Manufacturing facilities

Agios Pharmaceuticals Inc, Key Competitors

Agios Pharmaceuticals Inc, SWOT Analysis

Agios Pharmaceuticals Inc, Ratios based on current share price

Agios Pharmaceuticals Inc, Annual Ratios

Agios Pharmaceuticals Inc, Interim Ratios

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Agios Pharmaceuticals Inc, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History, Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts